We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.20
Bid: 56.00
Ask: 56.40
Change: -0.30 (-0.53%)
Spread: 0.40 (0.714%)
Open: 56.00
High: 56.00
Low: 56.00
Prev. Close: 56.50
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with PCG to evaluate Tricoya® plant

9 Jan 2019 07:00

RNS Number : 5607M
Accsys Technologies PLC
09 January 2019
 

9th January 2019 AIM: AXS

Euronext Amsterdam: AXS

 

ACCSYS TECHNOLOGIES PLC

("Accsys" or "the Company") 

Agreement with PCG to evaluate a Tricoya® plant in Malaysia

 

Accsys, the fast growing and sustainable chemical technology group, recently confirmed that it was exploring opportunities for new manufacturing plants outside Europe. Accsys is pleased to announce that its subsidiary, Tricoya Technologies Limited ("TTL"), has now entered into an agreement with PETRONAS Chemicals Group Berhad ("PCG") to evaluate the feasibility of jointly funding, designing, building and operating an integrated acetic anhydride and Tricoya® wood elements production plant (the "Plant") in Malaysia.

It is envisaged that Tricoya® wood elements produced at the Plant would use acetic acid from PCG's existing joint venture in Malaysia. The Plant would then supply the wood panel industry within South East Asia, under licence, as the key raw material for the formation of Tricoya® panels for the use in the construction industry in the region.

The evaluation is expected to include preliminary engineering studies, regional customer and market feasibility assessments and financing arrangements. Under the terms of the agreement, the parties have agreed to carry out the evaluation exclusively for a period of at least 18 months

Paul Clegg, Chief Executive of Accsys, said:

"This is an exciting and important step for Accsys, with the potential to open up new markets for Tricoya in Asia. We are really pleased to be exploring the expansion of our global manufacturing footprint with PCG, a major international chemical company, with such a strong Asian presence."

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014. The person responsible for arranging for the release of this Announcement on behalf of Accsys is Angus Dodwell, Legal Counsel & Company Secretary.

 

ACCSYS TECHNOLOGIES PLC

 ("Accsys" of "de Vennootschap")

 

Overeenkomst met PCG voor verkennend onderzoek naar Tricoya®-fabriek in Maleisië

Accsys, de snelgroeiende en duurzame chemische technologiegroep, heeft onlangs bevestigd dat het de mogelijkheden onderzoekt voor nieuwe productielocaties buiten Europa. Accsys is verheugd aan te kondigen dat haar dochteronderneming, Tricoya Technologies Ltd ("TTL"), een overeenkomst heeft gesloten met PETRONAS Chemicals Group Berhad ("PCG") om de haalbaarheid te onderzoeken van het gezamenlijk ontwerpen, bouwen en exploiteren van een geïntegreerde fabriek om azijnzuuranhydride en Tricoya®-houtelementen te produceren in Maleisië.

Het is de bedoeling dat de Tricoya®-houtelementen die in deze fabriek worden geproduceerd gebruikmaken van de azijnzuur van de bestaande joint venture van PCG in Maleisië. De nieuwe fabriek zal dan de geacetyleerde Tricoya®-houtelementen onder licentie leveren aan de houtplaatindustrie in Zuidoost-Azië als belangrijkste grondstof voor de productie van Tricoya®-platen die in de bouwsector in de regio worden gebruikt.

De evaluatie omvat zowel voorbereidende technische onderzoeken als een regionale haalbaarheidsstudie naar klanten en de markt alsmede onderzoek naar financieringsmogelijkheden. Als onderdeel van de overeenkomst zijn de partijen overeengekomen om het onderzoek exclusief voor een periode van ten minste 18 maanden uit te voeren.

Paul Clegg, Chief Executive van Accsys, licht toe:

"Dit is een spannende en belangrijke stap voor Accsys die ons mogelijkheden biedt om nieuwe markten voor Tricoya in Azië te betreden. We zijn erg blij dat we de uitbreiding van onze wereldwijde productie kunnen verkennen met PCG, een groot internationaal chemisch bedrijf met zo'n sterke aanwezigheid in Azië."

DEZE AANKONDIGING BEVAT INSIDE-INFORMATIE MET BETREKKING TOT ARTIKEL 7 VAN DE VERORDENING MARKTMISBRUIK EU 596/2014. De persoon die verantwoordelijk is voor het opstellen van deze aankondiging namens Accsys is Angus Dodwell, Juridisch Adviseur & Bedrijfssecretaris.

- Ends -

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

via MHP Communications

Numis Securities

Nominated Adviser:

Jamie Lillywhite

 

Corporate Broking:

Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

Off the Grid (The Netherlands)

Frank Neervoort

Yvonne Derkse

+31 681 734 236

+31 222 379 666

 

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a highly sustainable and environmentally responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of naturally occurring 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

Accsys Technologies is the trading name of Titan Wood Limited. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRLFFSLLLITIIA
Date   Source Headline
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM
12th Dec 20237:00 amRNSDirectorate Change
27th Nov 20239:57 amRNSNotifiable Interest - De Engh B.V.
27th Nov 20239:33 amRNSNotifiable Interest – Teslin
24th Nov 202312:21 pmRNSNotifiable Interest – De Engh B.V.
21st Nov 20233:37 pmRNSResults of Capital Raise
21st Nov 20237:04 amRNSHalf-year Report
21st Nov 20237:00 amRNSIssue of Equity
20th Sep 20235:12 pmRNSResults of Annual General Meeting 2023
15th Sep 20233:54 pmRNSNotifiable Interest - De Engh
12th Sep 20237:00 amRNSDirectorate Change
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTrading Update
17th Aug 20235:01 pmRNSNotice of Annual General Meeting 2023
28th Jul 20237:00 amRNSDirector Interests and LTIP Awards
26th Jul 20237:00 amRNSDirectorate Appointment
21st Jul 20233:46 pmRNSAnnual Report and Financial Statements 2023
27th Jun 20237:00 amRNSPreliminary results for the year end 31 March 2023
19th Jun 202312:48 pmRNSChange of Registered Office
6th Jun 20237:00 amRNSDirectorate Update
12th May 202311:21 amRNSBlock Listing Application to AIM
3rd May 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSCEO Appointment
24th Mar 20237:00 amRNSDirectorate Appointments
2nd Mar 20236:00 pmRNSBlock Listing Six Monthly Return
2nd Mar 20236:00 pmRNSTotal Voting Rights
26th Jan 20237:00 amRNSAccsys Trading Update
15th Dec 20223:55 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSDirectorate Change
6th Dec 20223:43 pmRNSNotifiable Interest - De Engh
6th Dec 20223:36 pmRNSNotifiable Interest - Teslin Participaties
22nd Nov 20227:00 amRNSInterim Results for six months ended 30 Sept 2022
17th Nov 20222:58 pmRNSIssue of Equity
10th Nov 20224:37 pmRNSHolding(s) in Company
8th Nov 20225:09 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSUpdate on Tricoya – Consortium restructure
1st Nov 20224:12 pmRNSNotice of HY Results and Total Voting Rights
23rd Sep 20224:20 pmRNSResult of AGM
12th Sep 20227:00 amRNSAccsys Trading Update
23rd Aug 20224:49 pmRNSNotice of AGM
23rd Aug 20222:35 pmRNSBlock Listing Application to AIM
3rd Aug 20227:00 amRNSDirectorate Change
27th Jul 20225:56 pmRNSAnnual Report
12th Jul 202210:40 amRNSDirector Interests and LTIP Awards
12th Jul 202210:16 amRNSGrant of Awards under Accsys Deferred Bonus Plan
30th Jun 20227:00 amRNSPreliminary results for the year end 31 March 2022
10th Jun 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.